IP Library Granted Patent US 8,987,501
Granted Patent B2
US 8,987,501 · App. 13/644,925 · Granted Mar 24, 2015

Isotopically labeled chemically stable reagents and process for the synthesis thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,987,501
App. No.
13/644,925
Granted
Mar 24, 2015
Kind
B2
Abstract

A radioisotope labeled reagent includes a compound having the general formula (I), L-( a C b H 2 ) n a C b H 3   (I) where a in each occurrence independently is a carbon mass number between 11 and 14 inclusive, b in each occurrence independently is a hydrogen mass number between 1 and 3 inclusive, such that a in each occurrence is not 12 simultaneously with b in each occurrence being 1; L is a leaving group R 1 SO 2 —O—, R 1 —S—, 12 C 1 H 3 ( 12 C 3 H 2 ) n —S—R 1 C(O)O—, NC—, (R 1 ) 3 P—, XMg- and Li—, where n is an integer between 0 and 3 inclusive, where X is chloro, bromo or iodine, where R 1 is H, aryl, a substituent containing aryl, C 1 -C 20 alkyl, a substituent containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, a substitute containing C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and a substitute containing C 2 -C 20 alkynyl with the proviso that when n is 0, a is 13 and b is 2 and R 1 in R 1 —S is not aryl.

Claims (28)

1. An isotopically labeled reagent comprising:

a compound having a formula

L-( a C b H 2 ) n a C b H 3   (I)

where a in each occurrence is independently a carbon atomic mass number of 11, 13 or 14, where b in every occurrence is a hydrogen atomic mass number of 1, 2 or 3, where L is a leaving group R 1 C(O)O—, where n is 0, where R 1 is a substituent containing aryl, C 3 -C 20 alkyl, a substituent containing C 3 -C 20 alkyl, C 4 -C 20 alkenyl, a substituent containing C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, or a substituent containing C 2 -C 20 alkynyl;

with the proviso that when R 1 is a substituent containing aryl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 1 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 3 alkyl, that said substituent is selected from the group consisting of: cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 1 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 2 alkenyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is a C 1 -C 6 alkyl; with the further proviso that when said substituent is a substituent containing phenyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 1 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 11 alkenyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 1 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 4 alkenyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is a C 1 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 6 alkenyl that said substituent is selected from the group consisting of: amino; cycloalkyl; nitro; halo; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 1 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 5 alkenyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of hydrogen, C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 1 -C 6 alkyl

with the proviso that when R 1 is a substituent containing C 4 alkyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 2 -C 6 alkyl;

with the proviso that when R 1 is a substituent containing C 8 alkyl that said substituent is selected from the group consisting of: amino; cycloalkyl; halo; nitro; cyano; —OR 2 wherein R 2 is selected from the group consisting of C 2 -C 6 alkyl, C 5 or C 6 cycloalkyl, a heterocycloalkyl, and a substituent containing phenyl; acyl; and —COOR 3 wherein R 3 is hydrogen or C 2 -C 6 alkyl.

2. The reagent of claim 1 wherein R 1 is said substituent containing aryl.

3. The reagent of claim 2 wherein said substituent further comprises a dye moiety.

4. The reagent of claim 3 wherein said dye moiety is selected from the group consisting of: cyanine and rhodamine.

5. The reagent of claim 1 wherein said leaving group is R 1 C(O)O—.

6. The reagent of claim 5 wherein R 1 is C 3 -C 6 alkyl.

7. The reagent of claim 1 wherein said leaving group is (C 6 H 5 )3P—.

8. A process for preparing a compound of Formula I according to claim 1 comprising the step of reacting a C b H 3 ( a C b H 2 ) n X with [L] y− M p Z+ where L is a leaving group R 1 C(O)O—, where M is a metal ion or onium ion, Z+ is a cationic valency of M, Y− is an anionic valency of L, P is the absolute value of the ionic valency divided by the cationic valency; and where the reaction occurs under anhydrous conditions in an aprotic solvent.

9. The process of claim 8 wherein a a C b H 3 ( a C b H 2 ) n X is reacted with [L] y− M p Z+ reagent.

10. The process of claim 8 wherein the step of reacting occurs with heating to a temperature less than or equal to a boiling temperature for said aprotic solvent.

11. The process of claim 8 wherein a C b H 3 ( a C b H 2 ) n X is reacted with 12 C 3 H 3 I.

12. A method of isotopically alkylating a target molecule comprising mixing under reaction conditions with said target molecule an effective amount of a compound of Formula I according to claim 1 .

13. The method of claim 12 wherein said target molecule is a nucleophile.

14. The method of claim 12 wherein said target molecule is a metallic salt of an organic anion.

15. The method of claim 12 wherein said target molecule is a tertiary amine.

16. The method of claim 12 wherein said compound of Formula I is XMg-, where n is an integer between 0 and 3 inclusive, where X is chloro, bromo or iodine, where R 1 is H, aryl, a substituent containing aryl, C 1 -C 20 alkyl, a substituent containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, a substituent containing C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and a substitute containing C 2 -C 20 alkynyl with the proviso that when n is 0, a is 13 and b is 2 and R 1 in R 1 —S is not aryl and said target molecule is a carboxylic acid, ester or amide.

Assignments (2)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 067006/0297 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2012
From: POUNDS, JERRY SCOT
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 029078/0421 →